IsoPlexis Corp
NASDAQ:ISO
IsoPlexis Corp
Cash & Cash Equivalents
IsoPlexis Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IsoPlexis Corp
NASDAQ:ISO
|
Cash & Cash Equivalents
$37.5m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash & Cash Equivalents
$5.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
38%
|
CAGR 10-Years
14%
|
|
Danaher Corp
NYSE:DHR
|
Cash & Cash Equivalents
$7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash & Cash Equivalents
$70.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash & Cash Equivalents
$1.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash & Cash Equivalents
$1.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
See Also
What is IsoPlexis Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
37.5m
USD
Based on the financial report for Dec 31, 2022, IsoPlexis Corp's Cash & Cash Equivalents amounts to 37.5m USD.
What is IsoPlexis Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
11%
Over the last year, the Cash & Cash Equivalents growth was -70%. The average annual Cash & Cash Equivalents growth rates for IsoPlexis Corp have been 11% over the past three years .